These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26823893)

  • 21. The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma.
    Shimomura Y; Takaki A; Wada N; Yasunaka T; Ikeda F; Maruyama T; Tamaki N; Uchida D; Onishi H; Kuwaki K; Nakamura S; Nouso K; Miyake Y; Koike K; Tomofuji T; Morita M; Yamamoto K; Okada H
    Intern Med; 2017; 56(3):243-251. PubMed ID: 28154266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma.
    Takakura K; Oikawa T; Tomita Y; Mizuno Y; Nakano M; Saeki C; Torisu Y; Saruta M
    World J Gastroenterol; 2018 May; 24(18):1989-1994. PubMed ID: 29760542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-alcoholic fatty liver disease and hepatocellular carcinoma in a 7-year-old obese boy: coincidence or comorbidity?
    Nobili V; Alisi A; Grimaldi C; Liccardo D; Francalanci P; Monti L; Castellano A; de Ville de Goyet J
    Pediatr Obes; 2014 Oct; 9(5):e99-e102. PubMed ID: 24302697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.
    Mikuriya Y; Tashiro H; Kobayashi T; Kuroda S; Abe T; Hashimoto M; Ohdan H
    Langenbecks Arch Surg; 2015 May; 400(4):471-6. PubMed ID: 25744657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoepithelioma-like hepatocellular carcinoma: Case report and review of the literature.
    Cacciato Insilla A; Faviana P; Pollina LE; De Simone P; Coletti L; Filipponi F; Campani D
    World J Gastroenterol; 2015 Sep; 21(36):10468-74. PubMed ID: 26420974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging features of hepatocellular carcinoma in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: a systematic review and meta-analysis.
    Park EJ; Son JH; Choi SH
    Abdom Radiol (NY); 2022 Jun; 47(6):2089-2098. PubMed ID: 35389074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?
    Stefano JT; de Oliveira CP; Corrêa-Giannella ML; Soares IC; Kubrusly MS; Bellodi-Privato M; de Mello ES; de Lima VM; Carrilho FJ; Alves VA
    Liver Int; 2011 Mar; 31(3):377-85. PubMed ID: 21108736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.
    Ertle J; Dechêne A; Sowa JP; Penndorf V; Herzer K; Kaiser G; Schlaak JF; Gerken G; Syn WK; Canbay A
    Int J Cancer; 2011 May; 128(10):2436-43. PubMed ID: 21128245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study.
    Yeh MM; Liu Y; Torbenson M
    Hum Pathol; 2015 Nov; 46(11):1769-75. PubMed ID: 26410018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult capillary hemangioma of the liver: case report and literature review.
    Jhuang JY; Lin LW; Hsieh MS
    Kaohsiung J Med Sci; 2011 Aug; 27(8):344-7. PubMed ID: 21802646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synchronous occurrence of a hepatic myelolipoma and two hepatocellular carcinomas.
    Xu SY; Xie HY; Zhou L; Zheng SS; Wang WL
    World J Gastroenterol; 2016 Nov; 22(43):9654-9660. PubMed ID: 27920487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma in noncirrhotic livers is associated with steatosis rather than steatohepatitis: potential implications for pathogenesis.
    van Meer S; van Erpecum KJ; Sprengers D; Klümpen HJ; Jansen PL; Ijzermans JN; Siersema PD; de Man RA; Verheij J
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):955-62. PubMed ID: 27196679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scirrhous hepatocellular carcinoma: comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection.
    Kim SH; Lim HK; Lee WJ; Choi D; Park CK
    Eur J Radiol; 2009 Jan; 69(1):123-30. PubMed ID: 17976942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens.
    Choi WT; Ramachandran R; Kakar S
    Hum Pathol; 2017 May; 63():1-13. PubMed ID: 28087475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
    Kodama T; Yi J; Newberg JY; Tien JC; Wu H; Finegold MJ; Kodama M; Wei Z; Tamura T; Takehara T; Johnson RL; Jenkins NA; Copeland NG
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10417-E10426. PubMed ID: 30327349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quantitative detection and clinical value of CD44 in patients with nonalcoholic fatty liver disease].
    Fang M; Yao M; Yang JL; Wang L; Sun JY; Wu MN; Yao DF; Tai BJ
    Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):994-1000. PubMed ID: 31941262
    [No Abstract]   [Full Text] [Related]  

  • 38. Atypically large well-differentiated hepatocellular carcinoma with extensive fatty metamorphosis: report of a case.
    Ishikawa D; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Mori H; Arakawa Y; Kanamoto M; Iwahashi S; Yamada S; Asanoma M
    J Med Invest; 2013; 60(3-4):267-71. PubMed ID: 24190046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of liver fatty acid binding protein in hepatocellular carcinoma.
    Cho SJ; Ferrell LD; Gill RM
    Hum Pathol; 2016 Apr; 50():135-9. PubMed ID: 26997447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Which animal models of nonalcoholic steatohepatitis-hepatocellular carcinoma (NASH-HCC) have more practical value in experimental investigations?].
    Duan NN; Wu J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):230-3. PubMed ID: 27095770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.